| Valco Consulting Firm | |
|
1111 Canyon View Ln Colton CA 92324-4713 | |
| (269) 363-9715 | |
| Not Available |
| Full Name | Valco Consulting Firm |
|---|---|
| Speciality | Pain Medicine |
| Location | 1111 Canyon View Ln, Colton, California |
| Authorized Official Name and Position | Wojtek Dajnowicz (PRESIDENT) |
| Authorized Official Contact | 6573450572 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Valco Consulting Firm 1111 Canyon View Ln Colton CA 92324-4713 Ph: (269) 363-9715 | Valco Consulting Firm 1111 Canyon View Ln Colton CA 92324-4713 Ph: (269) 363-9715 |
| NPI Number | 1295248441 |
|---|---|
| Provider Enumeration Date | 11/09/2017 |
| Last Update Date | 03/01/2018 |
| Medicare PECOS PAC ID | 5193087260 |
|---|---|
| Medicare Enrollment ID | O20180329002394 |
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
West Nile virus (WNV) has claimed the life of a 57-year old Orange County man, making him the first to die in California from the virus, Dr. Richard Joseph Jackson, state public health officer, announced today.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Bio-Optronics and Adventist Health System (AHS) have announced the implementation and initial rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the faith-based health care system's research institutes. This deployment, which included a CTMS-EMR integration with Cerner Millennium, will maximize process efficiency and enhance the organization's overall research quality.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295248441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | A144692 (California) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | (* (Not Available)) | Primary |
| Provider Name | Eckardt W Campos |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1932315868 PECOS PAC ID: 0547433922 Enrollment ID: I20111031000366 |
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
West Nile virus (WNV) has claimed the life of a 57-year old Orange County man, making him the first to die in California from the virus, Dr. Richard Joseph Jackson, state public health officer, announced today.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Bio-Optronics and Adventist Health System (AHS) have announced the implementation and initial rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the faith-based health care system's research institutes. This deployment, which included a CTMS-EMR integration with Cerner Millennium, will maximize process efficiency and enhance the organization's overall research quality.
› Verified 4 days ago
| Provider Name | Akil Simon |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1598100877 PECOS PAC ID: 6507121027 Enrollment ID: I20180601002298 |
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
West Nile virus (WNV) has claimed the life of a 57-year old Orange County man, making him the first to die in California from the virus, Dr. Richard Joseph Jackson, state public health officer, announced today.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Bio-Optronics and Adventist Health System (AHS) have announced the implementation and initial rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the faith-based health care system's research institutes. This deployment, which included a CTMS-EMR integration with Cerner Millennium, will maximize process efficiency and enhance the organization's overall research quality.
› Verified 4 days ago
| Provider Name | Ivan Rybkin |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1619364940 PECOS PAC ID: 1355679614 Enrollment ID: I20190823001874 |
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
West Nile virus (WNV) has claimed the life of a 57-year old Orange County man, making him the first to die in California from the virus, Dr. Richard Joseph Jackson, state public health officer, announced today.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Bio-Optronics and Adventist Health System (AHS) have announced the implementation and initial rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the faith-based health care system's research institutes. This deployment, which included a CTMS-EMR integration with Cerner Millennium, will maximize process efficiency and enhance the organization's overall research quality.
› Verified 4 days ago
| Provider Name | Bhaveen Kapadia |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1518344548 PECOS PAC ID: 6204249634 Enrollment ID: I20210104001454 |
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
West Nile virus (WNV) has claimed the life of a 57-year old Orange County man, making him the first to die in California from the virus, Dr. Richard Joseph Jackson, state public health officer, announced today.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Bio-Optronics and Adventist Health System (AHS) have announced the implementation and initial rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the faith-based health care system's research institutes. This deployment, which included a CTMS-EMR integration with Cerner Millennium, will maximize process efficiency and enhance the organization's overall research quality.
› Verified 4 days ago
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.
West Nile virus (WNV) has claimed the life of a 57-year old Orange County man, making him the first to die in California from the virus, Dr. Richard Joseph Jackson, state public health officer, announced today.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Bio-Optronics and Adventist Health System (AHS) have announced the implementation and initial rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the faith-based health care system's research institutes. This deployment, which included a CTMS-EMR integration with Cerner Millennium, will maximize process efficiency and enhance the organization's overall research quality.
› Verified 4 days ago
John F. Randolph,m.d.,inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 North Pepper Avenue, Colton, CA 92324 Phone: 909-580-1675 Fax: 909-580-1916 | |
Molina Medical Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1001 E Cooley Dr Ste 106, Colton, CA 92324 Phone: 909-825-8373 Fax: 909-825-3276 | |
Colton Clinica Medica Familiar Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 301 S La Cadena Dr, Colton, CA 92324 Phone: 909-219-5093 Fax: 909-219-5260 | |
Lizarraga Medical Clinic Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 895 W Valley Blvd, Colton, CA 92324 Phone: 909-824-3389 | |
Mt. Vernon Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1023 S Mount Vernon Ave, Colton, CA 92324 Phone: 909-422-8015 Fax: 909-422-0625 | |
Inland Empire Medical Group Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1550 E Washington St # 101, Colton, CA 92324 Phone: 800-418-0850 | |
Arrowhead Family Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-6230 Fax: 909-580-6308 |